Work

MO01.21 Phase 2 GEOMETRY Mono-1 Study: Capmatinib in Patients with METex14-mutated Advanced Non-Small Cell Lung Cancer who Received Prior Immunotherapy

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2020.10.069

Authors: R.S. Heist, J. Vansteenkiste, E. Smit, H. Groen, E. Garon, T. Hida, M. Nishio, K. Kokowski, C. Grohe, N. Reguart, A. Mansfield, A. Robeva, S. Ghebremariam, M. Waldron-Lynch, M. Akimov, N. Nwana, M. Giovannini, J. Wolf

Institutions: Harvard University, Massachusetts General Hospital, Universitair Ziekenhuis Leuven, The Netherlands Cancer Institute, University Medical Center Groningen, University of Groningen, University of California, Los Angeles, Aichi Cancer Center Hospital, The Cancer Institute Hospital, München Klinik Bogenhausen, Evangelische Lungenklinik Berlin, Hospital Clínic de Barcelona, Mayo Clinic, Novartis (Switzerland), Novartis (United States), University Hospital Cologne

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3119972493

Cites:

Cited by: 1

Related to: 10